Navigation Links
Kids Using Synthetic Pot a Growing Public Health Concern
Date:3/19/2012

By Alan Mozes
HealthDay Reporter

MONDAY, March 19 (HealthDay News) -- The recent advent of so-called "synthetic pot" is a rising public health concern, researchers warn, sending kids to the emergency room and prompting parental calls to poison control centers.

The concoction was originally conceived in a laboratory setting as a research aid for animal studies involving THC, a key stimulative ingredient in marijuana, the new report noted.

But purely recreational street use of this widely varying mix of plants and herbal ingredients is growing. It's widely available and is currently undetectable by commercial drug tests.

"The concern is that we're going to really see this grow in popularity," said study author Dr. Joanna Cohen, an assistant professor of pediatrics and emergency medicine at Children's National Medical Center, in Washington, D.C. "Because it's really easy to get, and because kids know that it doesn't come back on typical clinically useful urine drug screenings that we would use in an ER."

According to the American Association of Poison Control Centers, roughly 4,500 calls have come in since 2010 regarding toxicity stemming from synthetic marijuana use.

The new study appears online March 19 and in the April issue of Pediatrics.

Commonly referred to by a host of street names -- such as "K2," "Spice" and "Aroma" -- synthetic pot isn't made according to a fixed recipe and can differ from lab to lab and batch to batch.

The resulting product often includes some combination of blue and pink lotus, red clover, honey, vanilla, bay bean and marshmallow.

The blend -- which can be ingested either orally or via smoke inhalation -- is sprayed with chemicals that render the composition toxic.

Until recently, these synthetic mixtures were legal to purchase and readily available in corner stores and gas stations throughout the United States and on the Internet. In February, the U.S. Drug Enforcement Agency classified synthetic marijuana as a controlled substance.

That, Cohen cautioned, has done little to slow its popularity.

And because of it's strong impact on cannabinoid brain receptors, as little as 1 milligram of synthetic marijuana can be intoxicating, the study said. The impact can be stronger than that with naturally grown marijuana, sometimes prompting bouts of paranoia, anxiety, agitation, high blood pressure, profuse sweating, palpitations, irritability, muscle rigidity and, at times, convulsions.

The researchers noted that when users seek medical attention, the varied composition of synthetic pot can make it hard to quickly pinpoint the most dangerous ingredient.

Individual symptoms are usually short-lived, the researchers said, and treatment is available to help control some of the reactions.

In their report, Cohen and her team describe three case examples of teenaged patients who were hospitalized after using the drug, one girl and two boys.

Overall, the patients demonstrated varying degrees of catatonia, an inability to respond to verbal or physical stimulation -- including pain -- an elevated heart rate, agitation and anxiety, dizziness, headaches, excessive sweating, slowed speech, and confusion.

Two of the patients recovered normal function in three to four hours, while the third patient was kept in hospital overnight before being released.

"What's important with this is that parents and schools are aware that this is out there," Cohen said. "And that they look for signs and symptoms of use. If you see a teen who's agitated, sweating a lot, or acting abnormally in some way it could, of course, be a sign of a serious medical problem, or it could be a sign of drug toxicity. Either way you need to seek medical attention right away."

"The long-term the goal should be to prevent repeat use," she added, "because these kids are kids. They're teenagers and their brains are still developing. So there can be long-term effects, like psychosis and memory loss, from the use of something like synthetic marijuana."

Steven Shoptaw, a clinical psychologist and a professor in the department of family medicine at the University of California, Los Angeles, suggested that while current concerns surrounding synthetic pot use have some merit, they are dwarfed by the enormous popularity of real marijuana among teens.

"Because [synthetic marijuana] is a relatively new drug, the surveys that measure and monitor drug use in children over time haven't had a chance to look at this yet, so we don't know how big a problem this is across the country," he said.

"But what we do know is that the prevalence of marijuana use among eighth, ninth and tenth graders is very, very high," Shoptaw said. "And I would say that that's a much greater problem than 'Spice' use. Marijuana is actually way more available to teens, and it is very rich in potent THC. And that, as the authors point out, can pose a lot of problems for developing brains."

More information

For more on marijuana, synthetic and "natural," visit the U.S. National Library of Medicine.

SOURCES: Joanna Cohen, M.D., assistant professor, pediatrics and emergency medicine, division of pediatric emergency medicine, Children's National Medical Center, Washington, D.C.; Steven Shoptaw, Ph.D., clinical psychologist and professor, department of family medicine, University of California, Los Angeles; April 2012 Pediatrics


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Ecumen Building Senior Housing in Apple Valley, Minnesota and Will Manage New Maplewood, Minnesota Property
2. Using gold nanoparticles to hit cancer where it hurts
3. Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing
4. Register Online for this Year's Horst Senior Living Conference on April 8 Featuring Keynote Speaker and Senior Housing Expert Jim Moore
5. Rockland County Landlord Agrees to Settlement With United States to Protect Fair Housing Rights of Tenants With Mental Disabilities
6. Groundbreaking Study Using Ultrasound for the Treatment of Intracerebral and Intraventricular Hemorrhage Stroke Shows Promise
7. SDI Reports: Nearly a Third Of Physicians Use Handheld and Smartphone Devices to Access Medical Information - Physicians Most Likely to be Using Apple iPhone
8. Parrish Medical Center Sees 30 Percent Improvement in Mortality Using Real-Time Clinical Surveillance Solution from Thomson Reuters
9. Family history is strong predictor of obstructive coronary artery disease using CCTA
10. Using new approach, Mayo Clinic researchers find level of gene alters risk of Alzheimers disease
11. Best Selling, Non Toxic Skin Brightener Does the Job Using Safe, Healthy Ingredients and Introduces New Anti Aging Ingredients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Kids Using Synthetic Pot a Growing Public Health Concern
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: